CHIKV infection brings about MCP-induced cellular infiltration inside the inflamed joints, and bone loss is often ameliorated by treatment with an MCP-inhibiting drug, bindarit. Taken with each other, our knowledge reveal a previously undescribed position for MCPs in CHIKV-induced bone loss: considered one of recruiting monocytes/OC precursors to joint web https://carolyne443rcn6.blogthisbiz.com/profile